F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications.
about
Dietary Advanced Glycation End Products and Risk Factors for Chronic Disease: A Systematic Review of Randomised Controlled TrialsThe Mediterranean Lifestyle as a Non-Pharmacological and Natural Antioxidant for Healthy AgingEvidence in support of potential applications of lipid peroxidation products in cancer treatmentEffects of enriched environment on COX-2, leptin and eicosanoids in a mouse model of breast cancerLipid peroxidation generates biologically active phospholipids including oxidatively N-modified phospholipidsMetabonomics reveals drastic changes in anti-inflammatory/pro-resolving polyunsaturated fatty acids-derived lipid mediators in leprosy diseasePhospho-aspirin-2 (MDC-22) inhibits estrogen receptor positive breast cancer growth both in vitro and in vivo by a redox-dependent effectLipid anti-lipid antibody responses correlate with disease activity in systemic lupus erythematosusThe isoprostanes--25 years laterQuantitation of mercapturic acid conjugates of 4-hydroxy-2-nonenal and 4-oxo-2-nonenal metabolites in a smoking cessation studyOxidative Stress Biomarkers: Establishment of Reference Values for Isoprostanes, AOPP, and NPBI in Cord Blood.Measurement of isoprostanes as markers of oxidative stress in neuronal tissue.Urinary F2-isoprostanes, obesity, and weight gain in the IRAS cohortDo alterations in mitochondrial DNA play a role in breast carcinogenesis?F2-isoprostanes and Metabolite, and Breast Cancer Risk.Diabetes and cancer II: role of diabetes medications and influence of shared risk factors.Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivo.Influence of endothelial dysfunction on telomere length in subjects with metabolic syndrome: LIPGENE study.Inflammation, oxidative stress, glomerular filtration rate, and albuminuria in elderly men: a cross-sectional study.Effect of modest caloric restriction on oxidative stress in women, a randomized trial.Consumption of a high glycemic load but not a high glycemic index diet is marginally associated with oxidative stress in young women.Genetic and environmental influences on oxidative damage assessed in elderly Danish twins.Oxidative stress measured by urine F2-isoprostane level is associated with prostate cancerObesity, age, and oxidative stress in middle-aged and older women.Male infertility workup needs additional testing of expressed prostatic secretion and/or post-massage urinePhospho-aspirin (MDC-22) inhibits breast cancer in preclinical animal models: an effect mediated by EGFR inhibition, p53 acetylation and oxidative stressUrinary F2-isoprostanes and metabolic markers of fat oxidation.Oxidative stress mediates through apoptosis the anticancer effect of phospho-nonsteroidal anti-inflammatory drugs: implications for the role of oxidative stress in the action of anticancer agentsAre dietary antioxidant intake indices correlated to oxidative stress and inflammatory marker levels?The influence of oxidative stress on symptom occurrence, severity, and distress during childhood leukemia treatmentUrinary F2-isoprostanes as a biomarker of reduced risk of type 2 diabetes.Chemotherapeutic properties of phospho-nonsteroidal anti-inflammatory drugs, a new class of anticancer compounds.Measurement of isoprostanes as markers of oxidative stressAssociation of blood lead levels with urinary F₂-8α isoprostane and 8-hydroxy-2-deoxy-guanosine concentrations in first-grade Uruguayan children.Effects of Mountain Ultra-Marathon Running on ROS Production and Oxidative Damage by Micro-Invasive Analytic Techniques.Relation of blood cadmium, lead, and mercury levels to biomarkers of lipid peroxidation in premenopausal women.24-Hour ambulatory blood pressure associates inversely with prostaglandin F(2α), interleukin-6 and F(2)-isoprostane formation in a Swedish population of older men.Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron)Major metabolite of F2-isoprostane in urine may be a more sensitive biomarker of oxidative stress than isoprostane itself.Systemic markers of oxidative status and colorectal adenomatous polyps.
P2860
Q26764769-28EA0006-FFA1-431E-BE52-7F169A1FB6CFQ26771190-49B17CA7-9ECB-430E-823D-2F60B3BDDE4AQ26995265-A06F6156-CEB4-454C-A094-8572786D27A0Q27330395-EE6B28E6-F6F4-48DE-BAB4-05CA416F681AQ28389004-08B98DF4-76AE-41C9-A773-074750955AD4Q28535353-9CA39EDE-6044-4394-803B-E9692A46A1BAQ28544712-ACA3101D-9653-40BE-884C-27046FC77B80Q30588683-3C59274E-9F75-456B-A9CC-F35D6AD34FF5Q33601352-D7C6F156-12AE-4D48-BD52-B26BA0C693AFQ33636867-66DFF6A0-5471-42DC-9668-E3D64BE6B3D2Q33645487-64E076B6-9FE2-4201-B193-3F48BE837903Q33688993-8BE2C307-35F4-4EB8-BB3F-391C45D07B6FQ33950549-A5E0E162-11D4-4C57-8C87-B2E1A4E56CBCQ33985107-FA0E31DA-E22C-45DF-8C16-D244F4C8AE08Q34002533-58790153-8544-4BBD-9D98-A1D3021CCC85Q34069086-4780A24F-3B42-4B36-BF0F-FC2E1B2E2545Q34069534-D0D6C0A4-619D-4E73-A7A2-1600D55D186BQ34116106-BCDE7506-D634-4679-B614-4BD62E205D45Q34422837-64012722-58B8-4A4B-9D33-55BEE4D32B16Q34447871-4879AD88-57BD-4B46-841D-858BDD0E2D11Q34810203-2EF21C27-295D-4F75-BEEF-2CE4D61C4785Q34959146-C8B9B862-A229-4B46-A65F-5206F84BA598Q34977627-3B7B4170-E6A8-4B78-8357-7B3584519605Q34987129-2DCB1FC6-0706-45D0-807B-C2316D01B209Q35070507-87F51234-DB9C-4177-AE24-BF2D0F1E1BA0Q35103873-6CD2CBC5-5EA0-40B9-B3BE-36A7AD68F6F5Q35156825-AFCC77FC-2CD9-4239-B467-D2BD9C06B3E1Q35188164-0F5B6846-FFCD-44C9-B2E2-255C2D91A2F3Q35224129-509929E7-35B4-4CBC-9A9A-DE5D17F4E4A2Q35601630-D21AEDD1-83FE-4EB7-8B44-F2F37B6373D5Q35620138-0666AC5D-F792-4275-BB38-0330CE0E0247Q35624238-53ACA677-283A-4A57-AE5A-950B30E9A34DQ35751158-8B08D627-06A2-44C9-89EA-67A3486BCDBFQ35822504-71250C14-5397-4785-8393-3ACA0F1D2708Q35833664-295B13AF-9431-4D10-8D5C-CC54574E595CQ35883537-D1C9BDC6-1236-4966-8D3C-A6FF5D79731FQ35929612-E5DF5886-B131-4CA2-A828-4AAC07EEF826Q35960098-9A4BA85E-A9D2-49D3-A040-120C385C15D3Q36094027-4AFD5766-B6C7-446B-8244-347ED476FEB1Q36094808-105994CB-9FE5-4BC3-BF1F-CDEEC0E0F2C1
P2860
F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
F2-isoprostanes in human healt ...... isms to clinical implications.
@en
F2-isoprostanes in human healt ...... isms to clinical implications.
@nl
type
label
F2-isoprostanes in human healt ...... isms to clinical implications.
@en
F2-isoprostanes in human healt ...... isms to clinical implications.
@nl
prefLabel
F2-isoprostanes in human healt ...... isms to clinical implications.
@en
F2-isoprostanes in human healt ...... isms to clinical implications.
@nl
P356
P1476
F2-isoprostanes in human healt ...... isms to clinical implications.
@en
P2093
Samar Basu
P304
P356
10.1089/ARS.2007.1956
P577
2008-08-01T00:00:00Z